Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2) (N-Term) Peptid
PARK2
Reaktivität: Human
Wirt: Synthetic
BP, BI
Sodium azide
-
- Target Alle Parkin (PARK2) Produkte
- Parkin (PARK2) (Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2))
- Protein Region
- N-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), BioImaging (BI)
- Produktmerkmale
- 17 amino acids near the amino terminus of human PARK2.
-
-
- Applikationshinweise
- The peptide is used for blocking the activity of PARK2 Antibody . It usually blocks the antibody activity completely by incubating the peptide with equal volume of antibody for 30 min at 37˚,C.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Rekonstitution
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Konzentration
- 200 μg/mL
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store PARK2 Peptide at -20°C, stable for one year.
- Haltbarkeit
- 12 months
-
-
Sie sind hier:
